Share ownership Novo Nordisk A/S

NOVO B

DK0062498333

Pharmaceuticals

Market Closed - Nasdaq Copenhagen Other stock markets 11:20:00 2026-01-19 EST			5-day change	1st Jan Change
377.55 ^DKK	-2.92%		-0.41%	+16.08%

03:05am	Odin Norden Rises 1.96 Percent in December - Positive Stock Market Year Despite Turbulence	FW
01-16	Health Care Up as Wegovy Pill Buoys Novo Nordisk -- Health Care Roundup	DJ

Share class: Novo Nordisk A/S

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	10	1,075,000,000	0	0	70.25 %
Stock B	1	3,390,000,000	3,136,564,503 ( 92.52 %)	24,000,000 ( 0.708 %)

Major shareholders: Novo Nordisk A/S

Name	Equities	%	Valuation
Novo Holdings A/S (Investment Company) 5.238 %	177,560,500	5.238 %	9 093 M kr
NOVO NORDISK A/S 0.7654 %	25,947,151	0.7654 %	1 329 M kr
Nordea Investment Management AB 0.1362 %	4,615,714	0.1362 %	236 M kr
ODIN Forvaltning AS 0.1355 %	4,593,090	0.1355 %	235 M kr
Sjunde AP-fonden 0.1328 %	4,502,464	0.1328 %	231 M kr
State Street Global Advisors Ltd. 0.1264 %	4,286,450	0.1264 %	220 M kr
Nykredit Bank A/S (Investment Management) 0.125 %	4,236,678	0.125 %	217 M kr
ACATIS Investment Kapitalverwaltungsgesellschaft mbH 0.1107 %	3,752,984	0.1107 %	192 M kr
Capfi Delen Asset Management NV 0.0857 %	2,906,285	0.0857 %	149 M kr
Storebrand Asset Management AS 0.0813 %	2,755,326	0.0813 %	141 M kr
░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░

Name	Equities	%	Valuation
Caixa DTVM SA 0.000008 %	2,270	0.000008 %	14 857 kr

Name	Equities	%	Valuation
Novo Holdings A/S (Investment Company) 100 %	1,074,872,000	100 %	55 045 M kr
ANIMA Sgr SpA 0.0108 %	115,783	0.0108 %	6 M kr
Russell Investments Ltd. 0.000038 %	405	0.000038 %	20 741 kr

Name	Equities	%	Valuation
Capital Research & Management Co. (International Investors) 0.5225 %	17,713,424	0.5225 %	901 M kr
Loomis, Sayles & Co. LP 0.4768 %	16,165,468	0.4768 %	822 M kr
Fidelity Management & Research Co. LLC 0.4152 %	14,075,391	0.4152 %	716 M kr
Fiduciary Trust Company International 0.4125 %	13,984,789	0.4125 %	712 M kr
Merrill Lynch International 0.3954 %	13,403,378	0.3954 %	682 M kr
Eaton Vance Management 0.3662 %	12,413,429	0.3662 %	632 M kr
Fisher Asset Management LLC 0.3045 %	10,322,903	0.3045 %	525 M kr
Folketrygdfondet 0.3012 %	10,211,913	0.3012 %	520 M kr
Wells Fargo Bank NA 0.223 %	7,559,665	0.223 %	385 M kr
Fayez Sarofim & Co. LLC 0.2169 %	7,353,587	0.2169 %	374 M kr
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░

Breakdown by shareholder type

Institutional	47.64%
Other	1.18%
Novo Nordisk A/S	0.77%
State Street Corp.	0.18%
Markel Group, Inc.	0.07%
Individuals	0.01%
Banco Bilbao Vizcaya Argentaria SA	0.01%
SEI Investments Co.	0.01%
Menora Mivtachim Holdings Ltd.	0.01%
Unknown	50.12%

Based on 1000 largest holdings

Geographical origin of shareholders

Denmark	37.94%
United States	7.46%
United Kingdom	1.14%
Norway	0.75%
Sweden	0.39%
Canada	0.34%
Germany	0.34%
Finland	0.19%
Ireland	0.17%
Spain	0.16%
Luxembourg	0.16%
Italy	0.14%
France	0.13%
Belgium	0.1%
Switzerland	0.09%
Netherlands	0.07%
Australia	0.06%
Austria	0.05%
Japan	0.02%
Singapore	0.02%
Slovenia	0.02%
Israel	0.02%
Hong Kong	0.02%
South Africa	0.02%
Portugal	0.01%
Individuals	0.01%
Mexico	0.01%
Iceland	0.01%
Liechtenstein	0.01%
Puerto Rico	0.01%

Based on 1000 largest holdings

Novo Nordisk A/S specializes in the design, manufacture and marketing of pharmaceutical products. Net sales break down by family of products as follows: - diabetes and obesity treatment products (93.6%); - rare disease treatment products (6.4%): intended for the treatment of haemophilia, blood disorders, hormonal disorders, etc. Net sales are distributed geographically as follows: Europe/Middle East/Africa (20.8%), the United States (57.6%), North America (3.7%), China (6.4%) and other (11.5%).

Employees

78,554

Sector

Pharmaceuticals

Calendar

02-04 - Q4 2025 Earnings Release

More about the company